Value of Apoptotic, Antiapoptotic, and Cell Proliferation Markers in the Treatment of Graves’ Disease

Table 2

Expression of proliferation (Ki-67) and antiproliferation (p27) cell markers in thyrocytes and lymphocytes according to the diagnosis: Graves’ disease versus normal control (chi-square test/Fisher’s exact test).

Markers	%	Graves	Control	value
Ki-67 in thyrocytes	<1%	56.82%	85.71%	0.1254
	>1%	43.18%	14.29%
Ki-67 in lymphocytes	<1%	38.64%	71.43%	0.0001
	>1%	61.36%	28.57%
p27 in thyrocytes	<25%	18.18%	21.43%	0.6892
	>25%	81.82%	78.57%
p27 in lymphocytes	<25%	63.64	92.86%	<0.0001
	>25%	36.36%	7.14%